Leadership Team

Leadership Team

Our multidisciplinary Team, led by professionals with a long track record in drug development and management, relies on highly skilled personnel with unique competence in developing integrated solutions.

  • Alex Zwyer, MBA

    Chief Executive Officer & Co-Founder

    Former Executive Vice President of Viforpharma (Specialty Pharma)
    Global responsibility for marketing / sales, regulatory and medical affairs
    Re-purposing expert
    Named ‘Healthcare CEO of the Year, Switzerland’ in 2018 by Business Worldwide
    Named one of ‘The 10 Best Performing Leaders to Watch, 2018’ by Insight Success

  • Gregg Beloff J.D., MBA

    Chief Financial Officer

    More than 20 years of experience in the life science sector, ranging from venture-backed start-ups to publicly traded companies
    Previously served as CFO of two public and three privately held companies
    Gregg’s core expertise includes operational management, strategic planning and corporate and business development, fundraising and mergers and acquisitions
    Prior to his CFO roles, Gregg was a life science investment banker with Adams, Harkness & Hill, where he underwrote financings for and provided buy- and sell-side M&A counsel to biotechnology, medical device, and healthcare information technology companies
    Gregg holds a BA from Middlebury College, JD from the University of Pittsburgh School of Law and MBA from Carnegie Mellon University

  • Hervé Girsault, MBA

    Chief Business Officer

    CBO of PIQUR Therapeutics AG (Basel)
    CEO, Synarc Inc. (San Francisco, CA)
    Head Novartis Pharma Out-Licensing & Partnering
    Global Head M&A/BD Novartis Consumer Health
    CEO Novartis Consumer Health, Benelux
    CEO Gerber Products Company (France)

  • Jeff Newcorn, MD

    Chief Medical Officer
    (designated, currently working as a consultant)

    Professor of Psychiatry and Pediatrics
    Director, Division of ADHD and Learning Disorders; Icahn School of Medicine at Mount Sinai
    Director, Pediatric Psychopharmacology, Mount Sinai Health System
    Member of the Steering Committee of the NIMH-funded multicentre study ‘Multimodal Treatment of Children with ADHD (MTA)’ and the Primary Investigator on a NIMH-funded ADHD Research Infrastructure Network
    Study investigator in: close to 50 ADHD studies

  • Tim Wigal, PhD

    Chief Clinical Development Officer

    Director, Adult Clinical Services, AVIDA, Inc. Clinic (Newport Beach, CA)
    Former Director, Neurodevelopmental Disorders Research at Newport Beach Cl. Res. Associates
    Former Executive Director, University of California, Irvine (UCI) Child Development Center
    Principal Investigator (PI) at UCI of the ‘Multimodal Treatment of Children with ADHD (MTA)’ and PI of the Pre-schoolers with ADHD (PATS) projects
    Study investigator in: close to 100 ADHD studies